| |
GSTM1
| |
---|
Parameters
|
Variables
|
Present
|
Null
|
OR (95% Cl)
|
---|
Age (years)
|
>50
|
22
|
28
| |
|
>50
|
17
|
25
|
1.99 (0.531-7.44)
|
Status
|
Premenopausal
|
22
|
23
| |
|
Postmenopausal
|
17
|
30
|
0.59 (0.22-1.61)
|
Clinical tumour size
|
T2
|
15
|
16
| |
|
T3 + T4
|
24
|
37
|
1.7 (0.62-4.52)
|
Clinical nodal involvement
|
N0
|
14
|
11
| |
|
N1 + N2
|
25
|
42
|
3.02 (0.97-9.89)
|
Histologic grade
|
SBR1
|
8
|
6
| |
|
SBR2 + 3
|
31
|
47
|
2.4 (0.66-9.02)
|
Hormone receptors
|
HR-
|
17
|
19
| |
|
HR+
|
22
|
34
|
1.04 (0.38-2.80)
|
Pathological tumour size
|
pT0 + pT1
|
19
|
26
| |
|
pT2 + pT3
|
20
|
24
|
0.8 (0.32-2.08)
|
Involved nodes
|
pN-
|
10
|
9
| |
|
pN1+ pN3+
|
29
|
54
|
2.05 (0.67-6.27)
|
p53
|
Normal
|
31
|
33
| |
|
Mutated
|
8
|
20
|
2.7 (0.88-7.90)
|
- CI, confidence interval; OR, odds ratio.